Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
the largest Phase IIb trial with 536 participants failed to meet its primary efficacy endpoint, leading to development discontinuation in 2007
This information guides whether your provider suggests pausing, continuing, or switching to an oral formulation temporarily if available
Metabolic adaptation, water retention, measurement inaccuracies, underlying health conditions, and certain medications can all interfere with weight loss despite genuine efforts
2014;10(1 Suppl):S2632
US$ 22.18
US$ 25.57
US$ 20.56
US$ 26.64
US$ 23.27
US$ 20.17
